Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 29

1.

The role of kras mutations and MSI status in diagnosis of colorectal cancer.

Shemirani AI, Haghighi MM, Milanizadeh S, Taleghani MY, Fatemi SR, Damavand B, Akbari Z, Zali MR.

Gastroenterol Hepatol Bed Bench. 2011 Spring;4(2):70-5.

PMID:
24834160
[PubMed]
Free PMC Article
2.

Effectors of epidermal growth factor receptor pathway: the genetic profiling ofKRAS, BRAF, PIK3CA, NRAS mutations in colorectal cancer characteristics and personalized medicine.

Shen Y, Wang J, Han X, Yang H, Wang S, Lin D, Shi Y.

PLoS One. 2013 Dec 10;8(12):e81628. doi: 10.1371/journal.pone.0081628. eCollection 2013.

PMID:
24339949
[PubMed - in process]
Free PMC Article
3.

Personalized treatment for advanced colorectal cancer: KRAS and beyond.

Patel GS, Karapetis CS.

Cancer Manag Res. 2013 Nov 21;5:387-400. doi: 10.2147/CMAR.S35025. eCollection 2013. Review.

PMID:
24294007
[PubMed]
Free PMC Article
4.

Rechallenge therapy and treatment holiday: different strategies in management of metastatic colorectal cancer.

Tonini G, Imperatori M, Vincenzi B, Frezza AM, Santini D.

J Exp Clin Cancer Res. 2013 Nov 18;32:92. doi: 10.1186/1756-9966-32-92. Review.

PMID:
24245912
[PubMed - in process]
Free PMC Article
5.

Biological resonance for cancer metastasis, a new hypothesis based on comparisons between primary cancers and metastases.

Gao D, Li S.

Cancer Microenviron. 2013 Dec;6(3):213-30. doi: 10.1007/s12307-013-0138-y. Epub 2013 Nov 10.

PMID:
24214411
[PubMed]
Free PMC Article
6.

KRAS mutations and subtyping in colorectal cancer in Jordanian patients.

Elbjeirami WM, Sughayer MA.

Oncol Lett. 2012 Oct;4(4):705-710. Epub 2012 Jul 4.

PMID:
23205087
[PubMed]
Free PMC Article
7.

Prognostic and Predictive Roles of KRAS Mutation in Colorectal Cancer.

Arrington AK, Heinrich EL, Lee W, Duldulao M, Patel S, Sanchez J, Garcia-Aguilar J, Kim J.

Int J Mol Sci. 2012 Sep 25;13(10):12153-68. doi: 10.3390/ijms131012153.

PMID:
23202889
[PubMed]
Free PMC Article
8.

KRAS mutation testing in metastatic colorectal cancer.

Tan C, Du X.

World J Gastroenterol. 2012 Oct 7;18(37):5171-80. doi: 10.3748/wjg.v18.i37.5171. Review.

PMID:
23066310
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

KRAS mutation in colorectal cancer metastases after adjuvant FOLFOX for the primary.

Vauthey JN, Kopetz S, Aloia TA, Andreou A.

Br J Cancer. 2012 Oct 9;107(8):1442-3; author reply 1444. doi: 10.1038/bjc.2012.419. Epub 2012 Sep 27. No abstract available.

PMID:
23018559
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Adjuvant chemotherapy with FOLFOX for primary colorectal cancer is associated with increased somatic gene mutations and inferior survival in patients undergoing hepatectomy for metachronous liver metastases.

Andreou A, Kopetz S, Maru DM, Chen SS, Zimmitti G, Brouquet A, Shindoh J, Curley SA, Garrett C, Overman MJ, Aloia TA, Vauthey JN.

Ann Surg. 2012 Oct;256(4):642-50. doi: 10.1097/SLA.0b013e31826b4dcc.

PMID:
22968062
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Different metastatic pattern according to the KRAS mutational status and site-specific discordance of KRAS status in patients with colorectal cancer.

Kim MJ, Lee HS, Kim JH, Kim YJ, Kwon JH, Lee JO, Bang SM, Park KU, Kim DW, Kang SB, Kim JS, Lee JS, Lee KW.

BMC Cancer. 2012 Aug 9;12:347. doi: 10.1186/1471-2407-12-347.

PMID:
22876814
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Predictive Molecular Tumour Testing: What Are the Obstacles between Bench and Bedside?

Mileshkin L, Shah B, Michael M.

Chemother Res Pract. 2012;2012:838509. doi: 10.1155/2012/838509. Epub 2012 May 14.

PMID:
22666589
[PubMed]
Free PMC Article
13.

Comparative genomic analysis of primary versus metastatic colorectal carcinomas.

Vakiani E, Janakiraman M, Shen R, Sinha R, Zeng Z, Shia J, Cercek A, Kemeny N, D'Angelica M, Viale A, Heguy A, Paty P, Chan TA, Saltz LB, Weiser M, Solit DB.

J Clin Oncol. 2012 Aug 20;30(24):2956-62. doi: 10.1200/JCO.2011.38.2994. Epub 2012 Jun 4.

PMID:
22665543
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

KRAS mutations in primary tumours and post-FOLFOX metastatic lesions in cases of colorectal cancer.

Kawamoto Y, Tsuchihara K, Yoshino T, Ogasawara N, Kojima M, Takahashi M, Ochiai A, Bando H, Fuse N, Tahara M, Doi T, Esumi H, Komatsu Y, Ohtsu A.

Br J Cancer. 2012 Jul 10;107(2):340-4. doi: 10.1038/bjc.2012.218. Epub 2012 May 22.

PMID:
22617127
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

KRAS mutations testing in colorectal carcinoma patients in Italy: from guidelines to external quality assessment.

Normanno N, Pinto C, Castiglione F, Bardelli A, Gambacorta M, Botti G, Nappi O, Siena S, Ciardiello F, Taddei G, Marchetti A.

PLoS One. 2011;6(12):e29146. doi: 10.1371/journal.pone.0029146. Epub 2011 Dec 21.

PMID:
22216189
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Canadian Expert Group consensus recommendations: KRAS testing in colorectal cancer.

Aubin F, Gill S, Burkes R, Colwell B, Kamel-Reid S, Koski S, Pollett A, Samson B, Tehfe M, Wong R, Young S, Soulières D.

Curr Oncol. 2011 Aug;18(4):e180-4.

PMID:
21874108
[PubMed]
Free PMC Article
17.

Concordance of predictive markers for EGFR inhibitors in primary tumors and metastases in colorectal cancer: a review.

Baas JM, Krens LL, Guchelaar HJ, Morreau H, Gelderblom H.

Oncologist. 2011;16(9):1239-49. doi: 10.1634/theoncologist.2011-0024. Epub 2011 Jul 8. Review.

PMID:
21742964
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

KRAS, NRAS, PIK3CA exon 20, and BRAF genotypes in synchronous and metachronous primary colorectal cancers diagnostic and therapeutic implications.

Balschun K, Haag J, Wenke AK, von Schönfels W, Schwarz NT, Röcken C.

J Mol Diagn. 2011 Jul;13(4):436-45. doi: 10.1016/j.jmoldx.2011.03.002. Epub 2011 May 4.

PMID:
21704278
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Impact of KRAS Mutations on Management of Colorectal Carcinoma.

Sullivan KM, Kozuch PS.

Patholog Res Int. 2011 Mar 15;2011:219309. doi: 10.4061/2011/219309.

PMID:
21437184
[PubMed]
Free PMC Article
20.

KRAS mutation analysis: a comparison between primary tumours and matched liver metastases in 305 colorectal cancer patients.

Knijn N, Mekenkamp LJ, Klomp M, Vink-Börger ME, Tol J, Teerenstra S, Meijer JW, Tebar M, Riemersma S, van Krieken JH, Punt CJ, Nagtegaal ID.

Br J Cancer. 2011 Mar 15;104(6):1020-6. doi: 10.1038/bjc.2011.26. Epub 2011 Mar 1.

PMID:
21364579
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk